凯美拉治疗 KYMR
$131.73 +$3.61 (+2.82%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $131.07 -0.50%
开盘$129.41
昨收$128.12
当日区间$126.65 – $132.68
成交量787.0K
市值$11.25B
市盈率（TTM）–
股息率–
KYMR 相关新闻
匹配 Kymera Therapeutics 或代码 KYMR 的头条新闻，按最新排序。
- J.P. Morgan Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $140 正面
- J.P. Morgan Sticks to Its Buy Rating for Kymera Therapeutics (KYMR)
- J.P. Morgan Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $140
- Piper Sandler Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $140
- Stifel Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $152 正面
- BofA Securities Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $144 正面
- Wolfe Research Upgrades Kymera Therapeutics(KYMR.US) to Buy Rating, Announces Target Price $180 正面
- J.P. Morgan Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Announces Target Price $121
- BofA Securities Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Cuts Target Price to $123 负面
- A Quick Look at Today's Ratings for Kymera Therapeutics(KYMR.US), With a Forecast Between $116 to $139
- A Quick Look at Today's Ratings for Kymera Therapeutics(KYMR.US), With a Forecast Between $128 to $139
- Guggenheim Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $170 正面
- Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151 正面
- Stifel Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $132
- Analysts' Top Healthcare Picks: Metagenomi, Inc. (MGX), Kymera Therapeutics (KYMR)
暂无评论——快来第一个聊聊 KYMR。
登录后参与讨论。